Metabolic Syndrome and Obesity as Additional Factors That Determine Clinical Response in Chronic Hepatitis C

被引:20
|
作者
Purnak, Tugrul [1 ]
Efe, Cumali [2 ]
Beyazit, Yavuz [3 ]
Ozaslan, Ersan [1 ]
机构
[1] Ankara Numune Training & Res Hosp, Dept Gastroenterol, Ankara, Turkey
[2] Bitlis Govt Hosp, Dept Internal Med, Bitlis, Turkey
[3] Turkiye Yuksek Ihtisas Training & Res Hosp, Dept Gastroenterol, Ankara, Turkey
关键词
VITAMIN-D;
D O I
10.1002/hep.23734
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2229 / 2230
页数:2
相关论文
共 50 条
  • [41] Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes
    Magalhaes Oliveira, Lucivalda Pereira
    de Jesus, Rosangela P.
    Boulhosa, Ramona S. S. B.
    Mendes, Carlos Mauricio C.
    Lyra, Andre Castro
    Lyra, Luiz Guilherme C.
    CLINICS, 2012, 67 (03) : 219 - 223
  • [42] IS THERE A RISK TO DEVELOP OBESITY AND METABOLIC SYNDROME IN PATIENTS WITH CHRONIC HEPATITIS C AFTER TREATMENT-INDUCED LONG TERM VIROLOGICAL ERADICATION?
    Chambon-Augoyard, Christine
    Faure, Stephanie
    Pageaux, Georges-Philippe
    Daures, Jean-Pierre
    Larrey, Dominique G.
    HEPATOLOGY, 2011, 54 : 1127A - 1127A
  • [43] ANALYSIS OF CLINICAL AND VIROLOGICAL FACTORS ASSOCIATED WITH RESPONSE TO ALPHA-INTERFERON THERAPY IN CHRONIC HEPATITIS-C
    GARSON, JA
    BRILLANTI, S
    WHITBY, K
    FOLI, M
    DEAVILLE, R
    MASCI, C
    MIGLIOLI, M
    BARBARA, L
    JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (03) : 348 - 353
  • [44] Clinical and virological factors associated with complete response to re-treatment with interferon in the relapsers with chronic hepatitis C
    Watanabe, H
    Izumi, N
    Shimizu, M
    Noguchi, O
    Hoshino, Y
    Uchihara, M
    Miyake, S
    Sakai, T
    Enomoto, N
    Sato, C
    HEPATOLOGY, 1998, 28 (04) : 707A - 707A
  • [45] Association between chronic hepatitis C infection and metabolic syndrome: A meta-analysis
    Jiang, Yingling
    Zhou, Lihua
    NUTRITION CLINIQUE ET METABOLISME, 2022, 36 (03): : 197 - 202
  • [46] Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection
    Huang, Jee-Fu
    Huang, Chung-Feng
    Yu, Ming-Lung
    Dai, Chia-Yen
    Huang, Ching-I
    Yeh, Ming-Lun
    Hsieh, Meng-Hsuan
    Yang, Jeng-Fu
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Chern
    Chuang, Wan-Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (03) : 530 - 535
  • [47] Metabolic abnormalities in chronic hepatitis C - Introduction
    Capeau, Jacqueline
    Gharakanian, Shahin
    Younossi, Zobair M.
    LIVER INTERNATIONAL, 2009, 29 : 1 - 2
  • [48] Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C
    Altin, Zeynep
    Diniz, Gulden
    Colak, Ayfer
    Koyuncu, Betul
    Ozer, Serhat
    Aslan, Fatih
    Unsal, Belkis
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2019, 44 (02): : 170 - 176
  • [49] METABOLIC FACTORS HAVE NO INFLUENCE ON ACCURACY OF TRANSIENT ELASTOGRAPHY IN CHRONIC HEPATITIS B AND C
    Cardoso, Ana Carolina F.
    Carvalho-Filho, Roberto J.
    Stern, Christiane
    Laouenan, Cedric
    Di Pumpo, Alexandrine
    Giuily, Nathalie
    Asselah, Tarik
    Boyer, Nathalie
    El Ray, Ahmed
    Figueiredo-Mendes, Claudio G.
    Bedossa, Pierre
    Marcellin, Patrick
    HEPATOLOGY, 2010, 52 (04) : 1221A - 1221A
  • [50] Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C
    Myers, Robert P.
    Messous, Djamila
    Poynard, Thierry
    Imbert-Bismut, Francoise
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 21 (05) : 289 - 294